
Sign up to save your podcasts
Or


This comprehensive series explores the promising use of ketamine as an off-label treatment for treatment-resistant depression. Written by Dr. Chittaranjan Andrade, the articles detail how ketamine differs from conventional antidepressants by producing rapid and significant improvement (within hours). The series provides clinicians with practical guidance on this novel antidepressant approach that shows particular promise for patients who haven't responded to traditional treatments.
From the publisher's feed
This is an AI-generated podcast. NeuroMod brings you closer to the cutting-edge of interventional psychiatry by transforming essential literature into accessible audio summaries.…